首页> 外文期刊>The Journal of Allergy and Clinical Immunology >Oral versus repository corticosteroid therapy after hospitalization for treatment of asthma.
【24h】

Oral versus repository corticosteroid therapy after hospitalization for treatment of asthma.

机译:住院治疗哮喘后口服与糖皮质激素治疗。

获取原文
获取原文并翻译 | 示例
           

摘要

Tapering regimens of oral steroids may be difficult or confusing for some patients. Repository steroids have been shown to be as effective as tapering oral doses in preventing relapse after emergency treatment. This study was undertaken to determine whether repository steroids are as effective as tapering oral steroids in preventing relapse after hospitalization for treatment of asthma. Twenty-six patients with acute exacerbations of asthma requiring treatment for 24 to 72 hours with parenteral steroids were randomized into two groups. Both groups received oral prednisone, 60 mg daily, when parenteral steroids were discontinued. At discharge, one group received intramuscular placebo and oral prednisone tapered over 8 days, and the other received 80 mg intramuscular methylprednisolone sodium acetate and oral placebo. At discharge and 2-week follow-up, patients were interviewed and examined, and spirometry results were obtained. There was little difference between groups in ratings of symptoms at discharge or follow-up. Both groups had less wheezing at follow-up than at discharge, though the improvement was significant only in the repository steroid group (p < 0.05). Mean forced expiratory volume in 1 second, forced vital capacity, peak expiratory flow rate improved at follow-up in both groups. No significant differences in outcome were found between the oral and repository steroid groups.
机译:对某些患者而言,口服类固醇的逐渐减量方案可能很困难或令人困惑。储存类固醇在预防紧急治疗后预防复发方面已显示出与逐渐减少口服剂量同样有效。进行这项研究来确定储存类固醇在预防哮喘住院治疗后复发方面是否与减少口服类固醇一样有效。将26例需要胃肠外激素治疗24至72小时的哮喘急性加重患者随机分为两组。当停用肠胃外类固醇时,两组均接受口服泼尼松,每天60 mg。出院时,一组接受肌肉内安慰剂和口服泼尼松8天逐渐减少,另一组接受80 mg肌肉内甲基泼尼松龙醋酸钠和口服安慰剂。在出院和2周的随访中,对患者进行了访谈和检查,并获得了肺活量测定结果。两组在出院或随访时的症状等级差异不大。两组的喘息比出院时少,尽管改善仅在类固醇激素组中显着(p <0.05)。两组随访均显示1秒内的平均强制呼气量,强制肺活量,最大呼气流速提高。口服类固醇组和储存类固醇组在预后方面无显着差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号